To study the effect of Nalbuphine in prolongation of duration of post-operative analgesia when it is added as an adjuvant to 0.5%Ropivacaine in ultrasound guided supraclavicular brachial plexus blocks

The analgesic effect of Nalbuphine as an adjuvant to 0.5% Ropivacaine in Ultrasound Guided Supraclavicular Brachial Plexus Nerve Blocks : a prospective interventional study at SMS Hospital, Jaipur during 2021-2023.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043470

Enrollment

Registered

2022-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S52- Fracture of forearm

Interventions

Intervention1: inj. Nalbuphine: Inj. Nalbuphine 10mg(1ml) as an adjuvant to 0.5% Ropivacaine(20ml) in USG guided supraclavicular brachial plexus nerve block . After drug intervention, observation of p

Eligibility

Inclusion criteria

Inclusion criteria: 1.participant of fracture forearm surgeries under USG guided supraclavicular block. 2. ASA physical status class 1and 2 . 3. patients willing to participate.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy or hypersensitivity to either local anaesthetics or opioid group of drugs. 2. Any contra indication to peripheral nerve block. 3.impaired ability to communicate. 4.patients with raised intracranial tension. 5.pregnancy. 6.patient with coagulation disorder. 7.local infection/swelling at the site of injection.

Design outcomes

Primary

Measure	Time frame
Duration of post-operative analgesia according to NRS scale.(time of first request of rescue analgesia).Timepoint: Every 30 minutes in first hour then every one hourly in next twelve hours.	—

Secondary

Measure	Time frame
Haemodynamic parametersTimepoint: Intraoperative period;Mean duration of analgesiaTimepoint: In post-operative period;Proportion of cases with complicationsTimepoint: Post operative period;Side-effectsTimepoint: If any	—

Countries

India

Contacts

Public ContactDr Mohit Mathur

SMS MEDICAL COLLEGE AND HOSPITAL, JAIPUR

raghuvanshichitra@gmail.com9166609479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026